KEYWORDS chromogenic agar; Clostridium difficile; matrix-assisted laser desorption ionizationetime of flight Abstract The clinical workflow of using chromogenic agar and matrix-assisted laser desorption ionization time-of-fight mass spectrometry (MALDI-TOF MS) for Clostridium difficile identification was evaluated. The addition of MALDI-TOF MS identification after the chromID C. difficile chromogenic agar culture could significantly improve the diagnostic accuracy of C. difficile.
characteristics among Clostridium species, reliable species identification can only be determined by 16S rRNA gene sequencing from colonies isolated from cycloserine cefoxitin fructose agar. 7, 8 However, the procedures are complicated and time-consuming (8e12 hours). Starting in 2013, the implementation of chromogenic agar for C. difficile identification has been shown to improve the recovery rate and turn-around time. 9e13 However, the diagnostic specificity of the chromogenic agar for C. difficile was not clearly defined in the reports.
The objective of this study was to define the specificity of the commercial chromID C. difficile chromogenic agar (CDIFA; bioMérieux, Marcyl'E'toile, France) for C. difficile. We also tried to evaluate the practical importance of incorporating the matrix-assisted laser desorption ionization time-of-fight mass spectrometry (MALDI-TOF MS) for species confirmation after the chromogenic agar culture.
In brief, 686 soft stool or liquid stool specimens from 508 patients hospitalized in a healthcare network in Hong Kong, which included a university-affiliated hospital and three extended-care hospitals, were collected between February 28, 2014 and May 5, 2014. The specimens were plated directly onto CDIFA and onto Oxoid Clostridium difficile Selective Agar (CCFA) (Oxoid Ltd., Hamsphire, UK) for the clostridia culture. The media were incubated under an anaerobic condition for at most 72 hours. The cultures were examined after incubating for 24 hours, 48 hours, and 72 hours. Cultures showing no growth after 72 hours were confirmed as a negative culture. Once suspected flat and irregular gray-black colonies were found growing on the culture media within 72 hours, the incubation was stopped and further identification was followed up. The suspected colonies were identified by the Bruker Microflex LT MALDI-TOF MS (Bruker Daltonik, Bremen, Germany) by using the direct transfer method. Bacterial identification was matched with the Bruker spectra library program (version 4.0.0.1) that was preinstalled in the Bruker Biotyper device (version 3.1; Bruker.1). Cultures with ambiguous identification were further confirmed by a 1026 bp partial 16S rRNA gene sequencing. 14, 15 The diagnostic performance of the two media was analyzed statistically using MedCalc version 14.12.0 statistical software (MedCalc Software, Ostend, Belgium). Statistical analyses were performed using the Chi-square test and McNemar's test.
In general, gray-black irregular suspected C. difficile colonies could be observed in 21.6% (148/686 specimens) and 10.5% (72/686 specimens) of the CDIFA and CCFA cultures, respectively. On average, positive cultures from CDIFA could be observed at approximately 48 hours. By contrast, cultures from CCFA required 64 hours on average to grow. For species identification, we further identified the colonies by MALDI-TOF MS. Among the positive cultures, only 118 of the CDIFA cultures and 70 of the CCFA cultures were identified as C. difficile with a score > 2.0. The actual C. difficile recovery rate for CDIFA and CCFA was 17.2% (118/686 specimens) and 10.2% (70/686 specimens), respectively (p < 0.001; Figure 1 and Table 1 ).
For the 30 non-Clostridium difficile cultures growing on CDIFA, 28 cultures were identified as Clostridium hathewayi and the other two cultures were identified as Clostridium tertium and Clostridium disporicum. All non- Clostridium difficile specimens, except two C. hathewayi specimens, did not grow on CCFA. The morphology of the non-Clostridium difficile colonies growing on CDIFA was also gray-black and irregular, which was highly similar to the morphology of the C. difficile colonies. It was difficult to differentiate the two species by morphology and color change. The identities of these 30 non-Clostridium difficile specimens were further confirmed by 16S rRNA gene sequencing ( Table 2 ). Our study showed that the CDIFA had a much shorter average recovery time for C. difficile, compared to the CCFA (48 hours vs. 64 hours). This would allow the laboratory staff to alert the clinical microbiologists earlier that the clinical symptoms of the patients may be caused by C. difficile infection. The CDIFA also demonstrated a significantly higher C. difficile recovery rate than CCFA (21.6% vs. 10.5%; p < 0.001). However, the use of CDIFA alone for C. difficile direct culture could result in a 20.27% (30/148) false-positive rate. False-positive for non-Clostridium species growing on CDIFA has been reported in some studies, 10, 13, 16 although we found that all false-positive cultures isolated in this study were Clostridium species (e.g., C. hathewayi, C. disporicum, and C. tertium). These Clostridium species were all classified as commensal flora in healthy human feces. Clostridium hathewayi, which can cause disease once it gets into the bloodstream, 8, 17 was first recovered by CDIFA. However, this may be because of the prolonged incubation of CDIFA. Further investigation should be followed up.
By adding the MALDI-TOF MS after the CDIFA culture, the specificity and positive predictive value could be significantly improved from 94.72% to 100% and from 79.73% to 100%, respectively (p < 0.001). The false-positive culture on CDIFA could be solved by using MALDI-TOF MS as the confirmation tool. Because the MALDI-TOF MS step is simple and cheap, which the processing time and running cost is around 10 minutes and US$1, the MALDI-TOF MS is a more affordable confirmation test than the 16S rRNA gene sequencing for C. difficile identification. This rapid and reliable workflow for C. difficile identification would benefit the infection control of nosocomial antibioticassociated diarrhea. In conclusion, the CDIFA required short recovery time and showed high sensitivity to C. difficile. The CDIFA could also culture Clostridium species other than C. difficile; therefore, the addition of rapid MALDI-TOF MS after the CDIFA culture could significantly improve the diagnostic accuracy for C. difficile. We highlighted the importance of MALDI-TOF MS for correct species identification of C. difficile from clinical specimens and this workflow was highly recommended.
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